-

Shareholder Alert: Robbins LLP Announces That AgEagle Aerial Systems, Inc. (UAVS) is Being Sued for Misleading Shareholders

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of AgEagle Aerial Systems, Inc. (NYSE American: UAVS) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between September 3, 2019 and February 18, 2021. AgEagle is a commercial drone company.

If you suffered a loss due to AgEagle Aerial Systems, Inc.'s misconduct, click here.

AgEagle Aerial Systems, Inc. (UAVS) Misled Shareholders to Believe it Had Entered into a Contract with Amazon

According to the complaint, on September 3, 2019, AgEagle issued a press release announcing that it was entering the commercial drone package delivery market. In the release, then-CEO Barrett Mooney listed numerous companies that were "actively developing commercial drone-delivery service initiatives as part of their long-term strategic plans" and announced AgEagle's first purchase order to manufacture and assemble unmanned aerial vehicles "to meet the critical specifications for drones that are meant to carry goods in urban and suburban areas." Throughout the relevant period, defendants touted the impact of the purchase order on the Company, and made statements and took actions that led to speculation of a partnership between AgEagle and Amazon.

On October 14, 2020, The Wichita Business Journal broke the news that Amazon did not – and never had – a partnership agreement with AgEagle. Then, on February 18, 2021, Bonitas Research published a report revealing that AgEagle "was a pump & dump scheme orchestrated by … AgEagle founder and former chairman Bret Chilcott and other UAVS insiders to defraud U.S. investors." On this news, shares of AgEagle fell over $5.00, or more than 36%, to close at $8.96 on February 18, 2021, damaging investors.

If you purchased shares of AgEagle Aerial Systems, Inc. between September 3, 2019 and February 18, 2021, you have until April 26, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against AgEagle Aerial Systems, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome. 

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom